Dexamethasone
- Molecular formula
- C22H29FO5
- CAS Number
- 50-02-2
- IUPAC Name
- (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
- Molecular Weight
- 392.46g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.1570g/cm3
- Synonyms
- flumethasone
Identification
Interesting Facts about (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
This complex compound, known for its structured framework, is a fascinating example of how intricate molecular arrangements can lead to significant biological activity. Here are some noteworthy points:
- Steroid-like Framework: The compound has a steroid-like backbone, which is common in many biologically active molecules.
- Fluorine Substituents: The presence of fluorine atoms can enhance the compound’s biological activity and metabolic stability, making it a prime candidate for pharmaceutical development.
- Hydroxy Groups: The two hydroxy groups contribute to its potential hydrophilicity, influencing its interactions with biological systems.
- Biological Activity: Such compounds often exhibit properties such as anti-inflammatory, anti-cancer, or antiviral effects, showcasing their potential in therapeutic applications.
Furthermore, its stereochemistry, indicated by the specific R and S configurations, plays a crucial role in the compound’s biological interactions. As chemists often say, “The function of a compound is influenced by its structure,” and this compound is a perfect illustration of that principle. Each stereocenter contributes to how this molecule orients itself in a biological environment, impacting how it interacts with enzymes and receptors within living organisms.
As a testament to its complexity and potential, research into compounds like this one continues to unveil new insights into medicinal chemistry and the development of novel therapeutics.